BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25341889)

  • 1. Multilocus genetic risk scores for venous thromboembolism risk assessment.
    Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R
    J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PO-04 - A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy.
    Martín AJ; Ziyatdinov A; Rubio VC; Olmos VP; Huerta BM; Rodríguez JC; Fernández MS; de Castro EM; Caro RL; Fernández JM
    Thromb Res; 2016 Apr; 140 Suppl 1():S177-8. PubMed ID: 27161691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
    JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.
    Ziakas PD; Poulou LS; Pavlou M; Zintzaras E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
    Småbrekke B; Rinde LB; Evensen LH; Morelli VM; Hveem K; Gabrielsen ME; Njølstad I; Mathiesen EB; Rosendaal FR; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 Aug; 17(8):1363-1371. PubMed ID: 31124268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.
    Heit JA; Armasu SM; Asmann YW; Cunningham JM; Matsumoto ME; Petterson TM; De Andrade M
    J Thromb Haemost; 2012 Aug; 10(8):1521-31. PubMed ID: 22672568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism.
    Rubio-Terrés C; Soria JM; Morange PE; Souto JC; Suchon P; Mateo J; Saut N; Rubio-Rodríguez D; Sala J; Gracia A; Pich S; Salas E
    Appl Health Econ Health Policy; 2015 Apr; 13(2):233-42. PubMed ID: 25652150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
    Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ
    Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.
    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    Genet Med; 2011 Jan; 13(1):67-76. PubMed ID: 21150787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations.
    Salas E; Farm M; Pich S; Onelöv L; Guillen K; Ortega I; Antovic JP; Soria JM
    TH Open; 2021 Jul; 5(3):e303-e311. PubMed ID: 34263111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
    Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG
    CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism.
    Severinsen MT; Overvad K; Johnsen SP; Dethlefsen C; Madsen PH; Tjønneland A; Kristensen SR
    Br J Haematol; 2010 Apr; 149(2):273-9. PubMed ID: 20148880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?
    Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y
    Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173
    [No Abstract]   [Full Text] [Related]  

  • 17. Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
    Tormene D; Grandone E; De Stefano V; Tosetto A; Palareti G; Margaglione M; Castaman G; Rossi E; Ciminello A; Valdrè L; Legnani C; Tiscia GL; Bafunno V; Carraro S; Rodeghiero F; Simioni P
    Thromb Haemost; 2012 Mar; 107(3):477-84. PubMed ID: 22273731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.
    Segers O; Simioni P; Tormene D; Castoldi E
    Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gemmati D; Longo G; Franchini E; Araujo Silva J; Gallo I; Lunghi B; Moratelli S; Maestri I; Serino ML; Tisato V
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults: A Population-Based Cohort Study.
    Manderstedt E; Lind-Halldén C; Halldén C; Elf J; Svensson PJ; Dahlbäck B; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
    J Am Heart Assoc; 2022 Feb; 11(4):e023018. PubMed ID: 35112923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.